Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: A comparative study with immunostaining

11Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Objective: The main purpose of this retrospective study was to compare cyclin E expression levels in operable breast cancer patients determined using real-time RT-PCR and immunostaining. The prognostic relevance of cyclin E was also investigated. Methods: Specimens of invasive ductal breast cancer tissues obtained from 124 women during radical mastectomy were analyzed. Results: Of the tumor samples, 40.3 and 59.7% showed high expression of cyclin E in RT-PCR and immunostaining, respectively. The overall agreement probability was 0.032 according to Scott's π statistic. With a median follow-up of 55.5 months, cyclin E expression assessed using immunostaining was an independent negative prognostic factor in the node positive group (hazard ratio 3.1; 95% CI 1.0-9.2; P = 0.045). Cyclin E expression correlated with absence of steroid receptors and younger age. RT-PCR results did not predict survival in any group of patients. Conclusions: Disagreement between real-time RT-PCR and immunostaining was demonstrated. Immunostaining seems to be the more reliable method for assessing cyclin E in breast cancer cells. © 2006 Oxford University Press.

Cite

CITATION STYLE

APA

Potemski, P., Pluciennik, E., Bednarek, A. K., Kusinska, R., Jesionek-Kupnicka, D., Pasz-Walczak, G., … Kordek, R. (2006). Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: A comparative study with immunostaining. Japanese Journal of Clinical Oncology, 36(3), 142–149. https://doi.org/10.1093/jjco/hyi246

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free